Home / Stocks / RNA

RNA insider trading

Avidity Biosciences, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-10-17McCarthy Teresa
Chief Human Resources Officer
Sold20,000$50.15$1.0M
2025-09-05Boyce Sarah
President and CEO
Sold50,000$49.95$2.5M
2025-08-29Boyce Sarah
President and CEO
Sold25,000$49.39$1.2M
2025-08-15MacLean Michael F
Chief Financial Officer
Sold30,914$42.73$1.3M
2025-08-08Mosbrooker Eric
Chief Commercial Officer
Sold124,687$44.06$5.5M
2025-08-08LEVIN ARTHUR A
Director
Sold107,500$47.62$5.1M
2025-08-08Hughes Steven George
Chief Medical Officer
Sold33,983$42.74$1.5M
2024-12-19Boyce Sarah
President and CEO
Sold31,855$32.66$1.0M
2024-11-20McCarthy Teresa
Chief Human Resources Officer
Sold25,000$41.14$1.0M
2024-11-08MacLean Michael F
Chief Financial Officer
Sold92,444$45.59$4.2M
2024-10-17McCarthy Teresa
Chief Human Resources Officer
Sold25,000$48.52$1.2M
2024-10-09Thompson Tamar
Director
Sold30,000$44.98$1.3M
2024-10-03Flanagan W. Michael
CSTO
Sold62,500$47.62$3.0M
2024-09-23Boyce Sarah
President and CEO
Sold32,880$44.00$1.4M
2024-09-13Flanagan W. Michael
CSTO
Sold96,500$40.40$3.9M
2024-09-13McCarthy Teresa
Chief Human Resources Officer
Sold25,000$40.40$1.0M

See RNA on the chart

Every insider buy and sell for RNA plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.